The Win-Win Movement

The Short Title of:

“Global Health Catalyst Win- Win Movement”

Introduction: In December 2007, The Win-Win Scientific initiative was proposed by Professor Ahmed Elzawawy as an initiative of ICEDOC’s Experts in Cancer without Borders. &

It aims at the increase of affordability of better value cancer treatment in the world via exploring scientific approaches. All the stakeholders- particularly cancer patients and their families- could win! This also could lead to flourishing the business of pharmaceutical companies and Manufacturers of radiotherapy machines and medical devices without ruining a country or individuals economies. It is a Win-Win initiative. No one would lose!

There are 2 main wings of the win-win initiative:

- The first wing is “Exploring scientific approaches to increase affordability of better value cancer care”.
This includes cost effective, resource sparing cancer treatment and more important to get better value cancer control and care for cancer patients in the world via exploring scientific approaches and win-win scenarios.
- The second wing of the win-win initiative, was proposed in November, 2015 and declared in 29 April, 2016 during the Harvard Catalyst Summit. This wing regards catalyst action and professional advice to increase enormously the rate of establishment of services of clinical oncology in the world starting with the most difficult challenges in Africa.

In 29 April, 2016, The Win-Win Initiative has joined Harvard Global Health Catalyst and becomes one of its activities. Hence, the title of the initiative became in the period April 2016 till end of May 2019 “Harvard Global Health Catalyst Win-Win Initiative” ( Director : Prof. Wilfred Ngwa, Harvard Medical School, USA)

After May 2019 – Present: With the growth and progress of the Win-Win initiative and with increasing faculty from different institutes and experts in USA , Europe , Africa, South America and South Asia , different organizations , societies in the world , it becomes:

Global Health Catalyst Win-Win Movement

The short Title is

“The win-win Movement”

Executive Director: Prof. Wilfred Ngwa, Dana-Farber/Harvard Cancer Center, University of Massachusetts Lowell, Johns Hopkins University, USA.

At present, we are developing with partners and advisors the proposal of
“The Smart win-win global deal for cancer care”
(short title “ The smart win-win global deal”)
It is inspired from the win-win notions and our book “Approaching Global Oncology. The win-win model”.

“The Hunger , Health and cancer care. A call to all : Be Their voice “ . Prof. Ahmed Elzawawy , November 12, 2021

We are professional consultants and we are volunteer catalysts. We are NOT a funding body. We are NOT competing or replacing any society, organization, body, governmental or private efforts or individuals. But, we are facilitators and a forum for all. We are complementing and completing. We encourage all to do, to connect and to communicate with each other and to collaborate or to cooperate with one focus on how to increase the affordability of better value cancer care for the underserved patients in the world.

There is a great need for the Win-Win forum and movement. It is known that despite of current international and national efforts, organizations, societies, declarations, conferences and publications the huge gap between the required and available cancer care services in the world is increasing.

-Keynote speech of Prof. Ahmed Elzawawy ( in behalf of director and all faculty of GHC Win-Win Movement) in May 24, 219 , GHC Summit at Harvard Medical School , Boston, MA, USA

Series of Global Cancer Leaders

25 May , 2019
Prof Ahmed Elzawawy (Suez Canal University, Ismailia, Egypt) and Prof Eduardo Cazap (Editor-in-chief of ecancer) speak at the Global Health Catalyst Summit at Harvard Medical School , Boston , MA , USA 24-26 May, 2019 ,about global cancer care for the ecancer Global Oncology Leaders series. Their main topic of conversation is the increasing cost of drugs, moreover the total cost of treatment, and how to minimize this without compromising the outcome. Source from

- Prof. Ahmed Elzawawy, September 8, 2018
An Introduction to Affordability of Better Value Clinical Oncology.
Lecture: Online Course of Global Radiation Oncology (CaReER 18-19), Harvard Global Health Catalyst. Global Oncology University GO-U Click Here

- Ahmed Elzawawy (January 27th 2012). Science and Affordability of Cancer Drugs and Radiotherapy in the World - Win-Win Scenarios, Advances in Cancer Management, Ravinder Mohan, IntechOpen, DOI: 10.5772/22156

The main Channels of the Win-Win movement:

I- Catalyst actions and volunteer consultations : Corps of Catalysts, advisers and Win-Win consultants and

II- Scientific researches and publications (including this book). Some examples of publications and videos are in

III- The Global Oncology University GO-U and ecancer4all for online education plus onsite training. Link to Link Global Oncology University (GO-U) Collaborative win-win Education Model, 8th July, 2022

IV- Africa –Oxford- Harvard-Hopkins Cancer Research Consortium (AFROX-H2)

V- The Win-Win Ambassadors a) Honorary Ambassadors b) Professional Ambassadors

VI- Young catalysts Win-Win collaboration

VII- The Global Health Catalyst Summits: They are not just meetings, but summits to elaborate collaborations, partnerships and catalyst actions to empower the realization of the objective of Global Health Catalyst Win-Win movement for the sake of humans with cancer with special stress on Africa. Five annual summits were held in Harvard Medical School since 2015.

For more information, please feel free to download the following documents and videos. All your feedback, comments and contributions are welcomed

“Approaching global oncology: The win-win model”. Edited by Ahmed Elzawawy and Wilfred Ngwa. Publisher: IOP Publishing Ltd, Bristol, UK

-Elzawawy A. Breast Care Systemic Therapy: The need for more economically sustainable scientific strategies in the world. Breast Care 2008 Dec; 3(6): 434–438. Published online 2008 Nov 25. DOI: 10.1159/000170233

-Elzawawy A. The "Win-Win" initiative: a global, scientifically based approach to resource sparing treatment for systemic breast cancer therapy WORLD J SURG ONCOL , vol. 7, no. 1, pp. 44-5, 2009 . For more information click here

- Ahmed Elzawawy (January 27th 2012). Science and Affordability of Cancer Drugs and Radiotherapy in the World - Win-Win Scenarios, Advances in Cancer Management, Ravinder Mohan, IntechOpen, DOI: 10.5772/22156.

Minutes of The first brain storming meeting for the Win-Win Initiative. Click here

Ahmed Elzawawy . ASCO Connection 18 Aug 2012 RE: Global Health Equity. Click here

- Ahmed Elzawawy . Better Value Chemotherapy .In Muir Gray J A and Kerr D J (Eds) How to Get Better Value Cancer Care , Offox Press Ltd, Oxford , UK. 2013. Click here

-Spreading the Word on the Need for Cancer Control. PACT Partner Publishes New Concept 3 February 2012. Click here

-Elzawawy A, Kerr D. Variation in the availability of cancer drug generics in the United States of America. Ann Oncol 2013; 24 (suppl 5):v17-v22. Click here

-David Kerr and Ahmed Elzawawy. Targeted Therapies.Manufacturer sponsorship bias in economic analyses matters. Nat. Rev. Clin. Oncol. 9, 309–310 (2012 Nat. Rev. Clin. Oncol. 9, 309–310 (2012). Click here

-How the affordability of radiotherapy and essential cancer drugs improves breast cancer control in Africa: An example from Port Said, Egypt. (AORTIC 2013 Conference. November 23, 2013, Durban , South Africa ). Click here

-Ahmed Elzawawy’s Keynote Speech, 20-21 March, 2015 , Harvard Global Health Catalyst Summit at Harvard Medical School, Boston, MA, USA . Click here

-Elzawawy A (2015) The Shortage of Essential Cancer Drugs and Generics in the United States of America: Global Brain Storming Directions for the World. Int J Cancer Clin Res 2(2): 016. Click here

-Elzawawy AM (2015) Could African and Low- and Middle-Income Countries Contribute Scientifically to Global Cancer Care?. J Glob Oncol 1(2): 49-53. Click here

-Elzawawy A (2017) One More Proposal to Allocate Resources for the Win-Win Approaches to Increase the Affordability of Cancer Drugs and Radiotherapy in the World. J Cancer Prev Curr Res 7(5): 00250. DOI: 10.15406/jcpcr.2017.07.00250 Click here

-Expanding Global Access to Breast and Prostate Radiotherapy through Evidence-based Hypofractionation Techniques Irabor, O.C. et al. International Journal of Radiation Oncology • Biology • Physics, Volume 105, Issue 1, E12. Click here

- Ngwa, Wilfred, Twalib Ngoma, Anthony Zietman, Nina Mayr, Ahmed Elzawawy, Thomas A Winningham, Onyinye Balogun, et al. “Closing the Cancer Divide Through Ubuntu: Information and Communication Technology-Powered Models for Global Radiation Oncology.” International Journal of Radiation Oncology, Biology, Physics 94, no. 3 (March 2016): 440–49. Click here

- Irabor, O.C.; Swanson, W.J.; Shaukat, F.; Wirtz, J.; Mallum, A.A.; Ngoma, T.; Elzawawy, A.; Nguyen, P.; Incrocci, L.; Ngwa, W. Can the Adoption of Hypofractionation Guidelines Expand Global Radiotherapy Access? An Analysis for Breast and Prostate Radiotherapy. JCO Glob. Oncol. 2020
Published at on April 28, 2020:DOI 10.1200/JGO.19.00261

-Elzawawy A. Breast Cancer as a Model to Improve Outcome of Cancer Care in Low- and Middle-Income Countries has now been published in the following paginated issue of World Journal of Surgery: Volume 39, Issue 3 (2015), Page 693-694

-Porter A , Aref A, Chodounsky Z, Elzawawy A, Manatrakul N, Ngoma T , Orton C, Van’t Hooft E , Sikora k. A Global Strategy for Radiotherapy. A WHO consultation. Clinical Oncology 1999,11:368-370

Links to ecancer videos with Prof. Ahmed Elzawawy

Prof Ahmed Elzawawy on global cancer control

7 Videos with Professor Ahmed Elzawawy for ecancer from here

Economic and research benefits of the AORTIC meeting

November, 2019 at AORTIC
Prof Ahmed Elzawawy speaks to ecancer at AORTIC 2019 about the history and importance of the AORTIC meeting. He explains how AORTIC helps boost research, training and collaboration in Africa - as well as the 'win-win' outcome when increasing cancer awareness in Africa. Prof Elzawawy also discusses some of the important economic aspects and strategies to address surrounding cancer research in Africa. Source from

Developing a roadmap for cancer control in Africa

22 November, 2015
Prof Elzawawy talks to ecancertv at AORTIC 2015 about the development of a roadmap for cancer control in Africa. He stresses the importance of a multidisciplinary approach which looks at integrating pathology, palliative care, immunotherapy etc. This is, of course, a huge undertaking which involves the input of many organizations. He speaks with particular reference to the Lalla Salma Foundation in Morocco which is a good example, he says, of a local foundation with international connections that can help achieve a lot both regionally and internationally. Source from

Addressing disparities in access to clinicians

November, 2015
Prof Elzawawy talks to ecancertv at AORTIC 2015 about the various ways in which cancer care can be improved in Africa.
The fight for better value cancer care is important, he says, but the best long term benefits will be seen from the medical training of many more people.
The huge disparities between the number of clinicians in the developed and developing world are one of the main issues facing Africa, he says.
At the same time, Africa can still be a place for innovation in cancer care and offers, he argues, a wealth of diversity from which to develop research.
He notes the importance of online education and skill sharing.
Source from

Affordable radiotherapy and chemotherapy in Africa

November, 2013
Dr. Ahmed Elzawawy talks to ecancer at the 2013 AORTIC meeting about ways of implementing affordable radiotherapy and chemotherapy to Africa. Source from

Goals of AORTIC 2013 meeting

November, 2013
Message from President of AORTIC : Professor Ahmed Elzawawy
Dr Ahmed Elzawawy talks about the 2013 AORTIC meeting and the goals of the organisation over the next two years. Source from

Message from Professor Ahmed Elzawawy the president-elect of AORTIC

November, 2011
AORTIC (African Organisation for Research & Training In Cancer) is an African based non-governmental organisation dedicated to the promotion of cancer control and palliation in Africa. It has branches across the world and will soon be opening a new branch in Europe. Dr Ahmed Elzawawy, the president-elect, discusses the ‘win-win’ approach being used to bring affordable medication to African patients. It is hoped that this work can help increase early detection and consequently treatment success, can increase availability of palliative care and patient quality of life. Source from

Ahmed Elzawawy, MD
On behalf of the Win-Win movement- Global Health Catalyst. We are in an Orchestra!
Hence, it is Hand in Hand with:

1) The Win-Win Initiative of Global Health Catalyst .

Prof. Wil Ngwa , Director of Harvard Global Health Catalyst GHC & Prof. Paul Nugyen : Co-director of Harvard Global Health Catalyst GHC , Prof. Ahmed Elzawawy ( Chair, GHC Win-Win initiative) , Prof. David Kerr ( Oxford University, UK and Win-Win ), Prof. Eduardo Cazap ( Argentina, SLACOM and Win-Win ), Prof. Twalib Ngoma, (Tanzania and Win-Win), Prof. Stephan Avery ( Radiation Physics, Pen. University, USA and Win-Win) Prof. Riccardo Audisio (Sweden and Win-Win),Prof. Nicholas Abinya (Kenya and Win-Win)& Prof. Luca Incrocci ( Netherlands & Win-Win) , Prof. Golam A Zakaria ( Germany & Win) , Med.Phys. Holger Wirtz (Germany & Win-Win), Prof. Saiful Huq ( Win-Win and President Elect of American Association of Physicists in Medicine AAPM) and Prof. Bashkim Ziberi ( Balkan Win-Win) & Coordinators of Harvard GHC programs: Dr. Credit Omoruyi & Sayeda Yasmin-Karim, Ph.D, Dr, Lydia Asana & Dr. Neeharika Sinha & Dr. Romy Mueller& Kaylie Decosmo & Jana Wood & Noella Bih and William Swanson.

2) All the distinguished contributors, Win-Win Ambassadors and partners.

3) The Win-Win belongs to all and it will succeed only with the contribution of many. Welcome all!


Prof. Dr. Ahmed Elzawawy,
Founding President of ICEDOC
Websites: &
Emails: &
Executive Director:
Prof. Wilfred Ngwa, Dana-Farber/Harvard Cancer Center, University of Massachusetts Lowell and Johns Hopkins University, USA.